DENND4B
geneOn this page
Summary
DENND4B (DENN domain containing 4B, HGNC:29044) is a protein-coding gene on chromosome 1q21.3, encoding DENN domain-containing protein 4B (O75064). Guanine nucleotide exchange factor (GEF) which may activate RAB10.
Enables guanyl-nucleotide exchange factor activity. Involved in regulation of Rab protein signal transduction. Located in Golgi apparatus and nucleoplasm.
Source: NCBI Gene 9909 — RefSeq curated summary.
At a glance
- Gene–disease (curated): isolated cleft palate (Limited, GenCC)
- GWAS associations: 20
- Clinical variants (ClinVar): 243 total — 1 likely-pathogenic
- MANE Select transcript:
NM_014856
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29044 |
| Approved symbol | DENND4B |
| Name | DENN domain containing 4B |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000198837 |
| Ensembl biotype | protein_coding |
| OMIM | 619843 |
| Entrez | 9909 |
Gene structure
Transcript identifiers
Ensembl transcripts: 24 — 14 protein_coding, 9 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000361217, ENST00000368646, ENST00000462423, ENST00000464048, ENST00000472932, ENST00000474386, ENST00000477746, ENST00000480340, ENST00000483561, ENST00000485359, ENST00000492898, ENST00000494683, ENST00000531748, ENST00000877427, ENST00000877428, ENST00000877429, ENST00000877430, ENST00000877431, ENST00000912806, ENST00000912807, ENST00000912808, ENST00000912809, ENST00000912810, ENST00000912811
RefSeq mRNA: 2 — MANE Select: NM_014856
NM_001367466, NM_014856
CCDS: CCDS44228
Canonical transcript exons
ENST00000361217 — 28 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000895325 | 153941231 | 153941289 |
| ENSE00000895326 | 153940904 | 153941048 |
| ENSE00000895327 | 153940431 | 153940606 |
| ENSE00000895328 | 153940156 | 153940256 |
| ENSE00000895331 | 153939589 | 153939804 |
| ENSE00000895333 | 153938900 | 153939045 |
| ENSE00000895337 | 153937724 | 153937863 |
| ENSE00000895339 | 153937488 | 153937614 |
| ENSE00000895340 | 153936542 | 153936748 |
| ENSE00000895343 | 153936060 | 153936188 |
| ENSE00000895345 | 153934760 | 153934964 |
| ENSE00000895346 | 153934135 | 153934302 |
| ENSE00000895352 | 153933483 | 153933871 |
| ENSE00000895354 | 153933197 | 153933319 |
| ENSE00000895364 | 153930692 | 153930857 |
| ENSE00001415598 | 153946301 | 153946718 |
| ENSE00001628292 | 153942878 | 153943130 |
| ENSE00001632044 | 153941869 | 153942113 |
| ENSE00001637288 | 153942187 | 153942356 |
| ENSE00001781243 | 153942556 | 153942625 |
| ENSE00003518623 | 153930539 | 153930603 |
| ENSE00003529328 | 153941374 | 153941440 |
| ENSE00003551811 | 153932204 | 153932440 |
| ENSE00003594328 | 153944058 | 153944397 |
| ENSE00003622759 | 153932642 | 153932777 |
| ENSE00003646558 | 153930947 | 153931064 |
| ENSE00003681888 | 153929501 | 153930442 |
| ENSE00003791413 | 153932861 | 153933030 |
Expression profiles
Bgee: expression breadth ubiquitous, 289 present calls, max score 98.60.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.0887 / max 580.1176, expressed in 1754 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14737 | 5.3714 | 584 |
| 14740 | 4.4488 | 1534 |
| 14739 | 2.7547 | 1358 |
| 14736 | 0.9765 | 312 |
| 14734 | 0.3171 | 143 |
| 14741 | 0.1696 | 53 |
| 14735 | 0.0506 | 23 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 98.60 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 97.42 | gold quality |
| spleen | UBERON:0002106 | 97.33 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.71 | gold quality |
| cerebellar cortex | UBERON:0002129 | 96.66 | gold quality |
| lymph node | UBERON:0000029 | 96.36 | gold quality |
| cerebellum | UBERON:0002037 | 96.09 | gold quality |
| right frontal lobe | UBERON:0002810 | 95.84 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 95.69 | gold quality |
| blood | UBERON:0000178 | 95.63 | gold quality |
| right ovary | UBERON:0002118 | 95.53 | gold quality |
| apex of heart | UBERON:0002098 | 95.42 | gold quality |
| upper lobe of lung | UBERON:0008948 | 95.26 | gold quality |
| vermiform appendix | UBERON:0001154 | 95.18 | gold quality |
| monocyte | CL:0000576 | 94.97 | gold quality |
| mononuclear cell | CL:0000842 | 94.96 | gold quality |
| leukocyte | CL:0000738 | 94.93 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.91 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.90 | gold quality |
| body of uterus | UBERON:0009853 | 94.80 | gold quality |
| left ovary | UBERON:0002119 | 94.79 | gold quality |
| metanephros cortex | UBERON:0010533 | 94.74 | gold quality |
| tibial nerve | UBERON:0001323 | 94.63 | gold quality |
| endocervix | UBERON:0000458 | 94.60 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 94.57 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 94.51 | gold quality |
| olfactory bulb | UBERON:0002264 | 94.40 | silver quality |
| muscle of leg | UBERON:0001383 | 94.30 | gold quality |
| postcentral gyrus | UBERON:0002581 | 94.22 | gold quality |
| omental fat pad | UBERON:0010414 | 94.18 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
53 targeting DENND4B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3162-3P | 100.00 | 65.37 | 363 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-6126 | 99.62 | 68.09 | 996 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-208A-5P | 99.42 | 70.83 | 1913 |
| HSA-MIR-208B-5P | 99.42 | 70.83 | 1952 |
| HSA-MIR-548B-3P | 99.38 | 67.26 | 1000 |
| HSA-MIR-4685-5P | 99.25 | 65.99 | 1563 |
| HSA-MIR-6837-5P | 99.25 | 65.47 | 1632 |
| HSA-MIR-6734-3P | 99.15 | 66.27 | 1627 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dennd4b | ENSDARG00000102914 |
| mus_musculus | Dennd4b | ENSMUSG00000042404 |
| rattus_norvegicus | Dennd4b | ENSRNOG00000022373 |
| drosophila_melanogaster | Crag | FBGN0025864 |
| caenorhabditis_elegans | WBGENE00018681 |
Paralogs (3): DENND3 (ENSG00000105339), DENND4C (ENSG00000137145), DENND4A (ENSG00000174485)
Protein
Protein identifiers
DENN domain-containing protein 4B — O75064 (reviewed: O75064)
All UniProt accessions (3): O75064, E9PAK5, H0YEF0
UniProt curated annotations — full annotation on UniProt →
Function. Guanine nucleotide exchange factor (GEF) which may activate RAB10. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form.
Subcellular location. Golgi apparatus.
RefSeq proteins (2): NP_001354395, NP_055671* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001194 | cDENN_dom | Domain |
| IPR002885 | PPR_rpt | Repeat |
| IPR005112 | dDENN_dom | Domain |
| IPR005113 | uDENN_dom | Domain |
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR023341 | MABP | Domain |
| IPR037516 | Tripartite_DENN | Domain |
| IPR043153 | DENN_C | Homologous_superfamily |
| IPR051696 | DENN_Domain_GEFs | Family |
Pfam: PF02141, PF03455, PF03456
UniProt features (20 total): compositionally biased region 6, region of interest 5, domain 4, modified residue 2, repeat 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75064-F1 | 73.32 | 0.35 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 953, 1092
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs |
MSigDB gene sets: 108 (showing top):
MODULE_45, GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, REACTOME_MEMBRANE_TRAFFICKING, GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, MODULE_47, GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, chr1q21, GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, CHEN_METABOLIC_SYNDROM_NETWORK, KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP, KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP, GOBP_RAB_PROTEIN_SIGNAL_TRANSDUCTION
GO Biological Process (1): regulation of Rab protein signal transduction (GO:0032483)
GO Molecular Function (2): guanyl-nucleotide exchange factor activity (GO:0005085), protein binding (GO:0005515)
GO Cellular Component (5): nucleoplasm (GO:0005654), Golgi apparatus (GO:0005794), cytosol (GO:0005829), cytoplasmic vesicle (GO:0031410), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Rab regulation of trafficking | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cytoplasm | 3 |
| Rab protein signal transduction | 1 |
| regulation of small GTPase mediated signal transduction | 1 |
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular vesicle | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
596 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DENND4B | CRTC2 | Q53ET0 | 565 |
| DENND4B | RAB10 | P61026 | 432 |
| DENND4B | DENND1C | Q8IV53 | 420 |
| DENND4B | DENND5B | Q6ZUT9 | 414 |
| DENND4B | TMEM160 | Q9NX00 | 413 |
| DENND4B | DENND1A | Q8TEH3 | 402 |
| DENND4B | AVL9 | Q8NBF6 | 401 |
| DENND4B | C9orf43 | Q8TAL5 | 400 |
| DENND4B | ZNF709 | Q8N972 | 392 |
| DENND4B | RIC1 | Q4ADV7 | 380 |
| DENND4B | FAM219B | Q5XKK7 | 370 |
| DENND4B | KRABD2 | Q6ZNG9 | 370 |
| DENND4B | RAB3IL1 | Q8TBN0 | 370 |
| DENND4B | ZNF665 | Q9H7R5 | 348 |
| DENND4B | SLC39A1 | Q9NY26 | 348 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZMAT5 | DENND4B | psi-mi:“MI:0914”(association) | 0.530 |
| PLEKHJ1 | AP3B1 | psi-mi:“MI:0914”(association) | 0.350 |
| PLEKHJ1 | DENND4B | psi-mi:“MI:0914”(association) | 0.350 |
| CALM1 | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
| DENND4B | rpoB | psi-mi:“MI:0915”(physical association) | 0.000 |
| DENND4B | psi-mi:“MI:0915”(physical association) | 0.000 | |
| DENND4B | manY | psi-mi:“MI:0915”(physical association) | 0.000 |
| argE | DENND4B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (22): DENND4B (Affinity Capture-MS), DENND4B (Affinity Capture-MS), DENND4B (Proximity Label-MS), DENND4B (Proximity Label-MS), DENND4B (Proximity Label-MS), DENND4B (Proximity Label-MS), DENND4B (Proximity Label-MS), DENND4B (Proximity Label-MS), DENND4B (Proximity Label-MS), DENND4B (Proximity Label-MS), DENND4B (Proximity Label-MS), DENND4B (Proximity Label-MS), DENND4B (Affinity Capture-RNA), DENND4B (Affinity Capture-MS), DENND4B (Affinity Capture-MS)
ESM2 similar proteins: A0A061IR73, A0A7N9VSG0, A7YSY2, D3KCC4, D3ZU57, D4A2B7, O08644, O15197, O19179, O43542, O75064, O95382, P0C0K6, P0C0K7, P51840, P52785, P52824, P54777, Q02846, Q05932, Q13470, Q13608, Q1HG60, Q3ZBE0, Q4KM32, Q5JZY3, Q643R3, Q6MG64, Q6NVG1, Q6ZPS2, Q76MJ5, Q7TNJ2, Q80SX8, Q8BYG9, Q8IZY2, Q8NFF5, Q8R5G7, Q8TDZ2, Q8WWN8, Q91V24
Diamond homologs: A6H8H2, G2WWH6, O75064, Q3U1Y4, Q5VZ89, Q7Z401, Q9W3D3, E9PXF8, I1RQE2, O02626, O95248, P78524, Q3U1T9, Q68D51, Q68F67, Q6NTN5, Q6P3S1, Q6ZPE2, Q86WG5, Q8C4S8, Q8CFK6, Q8IV53, Q8K382, Q8TEH3, Q91VV4, Q924W7, Q9H6A0, Q9TXP3, Q9ULE3, Q9Y7Q7, X0JZ91, Q80U28, Q9VXY2, O08873, Q8WXG6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
243 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 175 |
| Likely benign | 24 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 599505 | NM_014856.3(DENND4B):c.1825C>T (p.Leu609Phe) | Likely pathogenic |
SpliceAI
4137 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:153930438:GGCCA:G | acceptor_gain | 1.0000 |
| 1:153930439:GCCA:G | acceptor_gain | 1.0000 |
| 1:153930440:CCA:C | acceptor_gain | 1.0000 |
| 1:153930440:CCAC:C | acceptor_gain | 1.0000 |
| 1:153930441:CA:C | acceptor_gain | 1.0000 |
| 1:153930441:CAC:C | acceptor_gain | 1.0000 |
| 1:153930442:AC:A | acceptor_loss | 1.0000 |
| 1:153930443:C:CC | acceptor_gain | 1.0000 |
| 1:153930443:CTAG:C | acceptor_loss | 1.0000 |
| 1:153930602:CCCTT:C | acceptor_gain | 1.0000 |
| 1:153930603:CCTT:C | acceptor_gain | 1.0000 |
| 1:153930691:CCT:C | donor_gain | 1.0000 |
| 1:153930853:CTGGC:C | acceptor_gain | 1.0000 |
| 1:153930858:C:CC | acceptor_gain | 1.0000 |
| 1:153930862:A:AC | acceptor_gain | 1.0000 |
| 1:153930862:A:C | acceptor_gain | 1.0000 |
| 1:153932640:AC:A | donor_gain | 1.0000 |
| 1:153932640:ACC:A | donor_gain | 1.0000 |
| 1:153932640:ACCC:A | donor_gain | 1.0000 |
| 1:153932641:CC:C | donor_gain | 1.0000 |
| 1:153932641:CCC:C | donor_gain | 1.0000 |
| 1:153932641:CCCC:C | donor_gain | 1.0000 |
| 1:153932774:GACA:G | acceptor_gain | 1.0000 |
| 1:153932776:CA:C | acceptor_gain | 1.0000 |
| 1:153932778:C:CC | acceptor_gain | 1.0000 |
| 1:153933195:A:AC | donor_gain | 1.0000 |
| 1:153933196:C:CC | donor_gain | 1.0000 |
| 1:153933198:T:TA | donor_gain | 1.0000 |
| 1:153934133:A:AC | donor_gain | 1.0000 |
| 1:153934134:C:CT | donor_gain | 1.0000 |
AlphaMissense
9494 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:153932289:A:G | L1304P | 0.999 |
| 1:153932364:A:G | L1279P | 0.999 |
| 1:153932373:A:G | L1276P | 0.999 |
| 1:153932385:A:G | L1272P | 0.999 |
| 1:153932396:G:C | S1268R | 0.999 |
| 1:153932396:G:T | S1268R | 0.999 |
| 1:153932398:T:G | S1268R | 0.999 |
| 1:153932925:A:G | C1187R | 0.999 |
| 1:153932958:A:G | W1176R | 0.999 |
| 1:153932958:A:T | W1176R | 0.999 |
| 1:153933006:A:G | C1160R | 0.999 |
| 1:153936658:A:G | W775R | 0.999 |
| 1:153936658:A:T | W775R | 0.999 |
| 1:153940513:C:G | G474R | 0.999 |
| 1:153941381:A:G | L372P | 0.999 |
| 1:153941384:A:G | I371T | 0.999 |
| 1:153941384:A:T | I371N | 0.999 |
| 1:153941426:A:G | F357S | 0.999 |
| 1:153941435:A:T | I354N | 0.999 |
| 1:153942289:G:C | F236L | 0.999 |
| 1:153942289:G:T | F236L | 0.999 |
| 1:153942291:A:G | F236L | 0.999 |
| 1:153930425:A:C | Y1455D | 0.998 |
| 1:153931006:T:A | D1352V | 0.998 |
| 1:153932291:G:C | N1303K | 0.998 |
| 1:153932291:G:T | N1303K | 0.998 |
| 1:153932377:C:T | E1275K | 0.998 |
| 1:153932378:C:A | K1274N | 0.998 |
| 1:153932378:C:G | K1274N | 0.998 |
| 1:153932394:G:C | P1269R | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000021969 (1:153943317 C>T), RS1000054409 (1:153943669 CTCTG>C), RS1000595720 (1:153948499 T>C,G), RS1001146282 (1:153935070 A>T), RS1001588165 (1:153947776 G>A,C), RS1001699815 (1:153941494 C>G), RS1001730887 (1:153941804 C>G,T), RS1002022604 (1:153934428 T>TGTTG), RS1002064838 (1:153940079 T>C,G), RS1002170933 (1:153943193 G>A,C,T), RS1002309124 (1:153932055 C>G,T), RS1002515614 (1:153936771 C>G), RS1002592007 (1:153935193 C>T), RS1002674572 (1:153929904 C>G), RS1002680399 (1:153947142 G>A)
Disease associations
OMIM: gene MIM:619843 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| isolated cleft palate | Limited | Unknown |
Mondo (1): isolated cleft palate (MONDO:0007336)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
20 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001640_7 | Lentiform nucleus volume | 5.000000e-06 |
| GCST003795_1 | Age at first birth | 6.000000e-10 |
| GCST005751_3 | Empathy quotient | 3.000000e-07 |
| GCST006044_1 | Age at first birth | 3.000000e-07 |
| GCST006045_3 | Age at first birth | 5.000000e-06 |
| GCST006083_15 | Prostate cancer (advanced) | 8.000000e-07 |
| GCST006085_110 | Prostate cancer | 5.000000e-14 |
| GCST010136_18 | Fruit consumption | 3.000000e-08 |
| GCST010137_3 | Cooked vegetable consumption | 3.000000e-09 |
| GCST010138_14 | Raw vegetable consumption | 5.000000e-11 |
| GCST010142_60 | Fish- and plant-related diet | 4.000000e-09 |
| GCST010142_92 | Fish- and plant-related diet | 6.000000e-14 |
| GCST010696_22 | Cortical thickness (min-P) | 4.000000e-10 |
| GCST010697_50 | Cortical surface area (min-P) | 1.000000e-12 |
| GCST010698_81 | Subcortical volume (min-P) | 1.000000e-23 |
| GCST010699_7 | Brain morphology (min-P) | 1.000000e-10 |
| GCST010700_11 | Cortical thickness (MOSTest) | 4.000000e-13 |
| GCST010701_73 | Cortical surface area (MOSTest) | 4.000000e-09 |
| GCST010702_45 | Subcortical volume (MOSTest) | 4.000000e-10 |
| GCST010703_276 | Brain morphology (MOSTest) | 2.000000e-15 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009101 | age at first birth measurement |
| EFO:0009183 | empathy measurement |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs8450 | CRTC2, DENND4B | 3 | 5.25 | 1 | cyclosporine;tacrolimus |
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, increases expression | 2 |
| Valproic Acid | affects expression, increases methylation | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| decabromobiphenyl ether | decreases expression | 1 |
| trichostatin A | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| abrine | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
| hexabrominated diphenyl ether 153 | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Bortezomib | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Vorinostat | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Ozone | increases abundance, affects expression | 1 |
| Smoke | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1PZ | Abcam HeLa DENND4B KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: isolated cleft palate
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): isolated cleft palate